logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumab/Nivolumab/Nivolumab/relatlimabVarious toxicities: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2025年 / 2056卷 / 1期
关键词:
D O I:
10.1007/s40278-025-81637-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:265 / 265
相关论文
共 50 条
  • [1] Nivolumab/relatlimabVarious toxicities: case report
    Reactions Weekly, 2024, 2021 (1) : 429 - 429
  • [2] Ipilimumab/nivolumab/nivolumab/prednisoneVarious toxicities: case report
    Reactions Weekly, 2023, 1963 (1) : 305 - 305
  • [3] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: case report
    Reactions Weekly, 2017, 1668 (1) : 232 - 232
  • [4] Ipilimumab/nivolumab interactionVarious toxicities: case report
    Reactions Weekly, 2017, 1680 (1) : 192 - 192
  • [5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: case report
    Reactions Weekly, 2018, 1685 (1) : 118 - 118
  • [6] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: case report
    Reactions Weekly, 2024, 2036 (1) : 236 - 236
  • [7] Ipilimumab/nivolumab/prednisoneVarious toxicities: case report
    Reactions Weekly, 2022, 1893 (1) : 194 - 194
  • [8] Ipilimumab/nivolumab/tozinameranVarious toxicities: case report
    Reactions Weekly, 2023, 1960 (1) : 249 - 249
  • [9] Ipilimumab/nivolumab/prednisoneVarious toxicities: case report
    Reactions Weekly, 2019, 1782 (1) : 187 - 187
  • [10] Ipilimumab/nivolumab/methylprednisoloneVarious toxicities: case report
    Reactions Weekly, 2022, 1896 (1) : 255 - 255
← 12345 →